Greetings!

Welcome to the QPS Pharmacology Newsletter

This month, we're spotlighting our Psoriasis Pharmacology Model, following last month's feature on the IBD Model. Additionally, learn more about QPS India and stay updated with the latest research on the QPS Blog.

Pharmacology Models Available Today

QPS is proud to announce the availability of our newest pharmacology model, an Imiquimod (IMQ)-induced psoriasis model. This model has been developed in our state-of-the-art laboratories along side our MASH, ulcerative colitis and wound healing pharmacology models.

To best support our clients, we utilize or adapt existing models, or develop new ones tailored to your specific research needs. Please reach out for more information or to get your next study started.

Contact QPS to Start Your Next Pharmacology Study

QPS Biotransformation Studies

In the context of drug development, preclinical biotransformation studies involve investigating how a drug candidate is metabolized in laboratory animals before advancing to clinical trials in humans.

Key QPS Capabilities:

Identify metabolic pathways and metabolites
Assess drug efficacy and safety
Detect potential toxicities and adverse effects
Inform dosing strategies and predict human drug behavior

Trust QPS to Conduct Your Next Biotransformation Study

Contact the Experts at QPS

Request a meeting with the QPS bioanalysis, preclinical and clinical research experts to learn more about our capabilities as a full-service, global CRO.

Contact QPS Today

Discover the Future of Science on the QPS Blog

Slowing the Clock: Trial Delivers Hope in Delaying Alzheimer’s Disease

People with a rare genetic form of Alzheimer’s disease can begin to experience memory loss and dementia starting in their 30s, 40s and 50s. Although this form of the disease, known as...

More Trials Ahead

Read More about Pharmacology at QPS

Click Here to Subscribe to the QPS Blog

Visit our website www.qps.com

or contact us at info@qps.com

for an appointment.

www.qps.com | info@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)